Global Next Generation Sequencers Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Next Generation Sequencers Market Research Report 2024
Next generatio sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. The advent of rapid DNA sequencing methods has greatly accelerated biological and medical research and discovery.
Knowledge of DNA sequences has become indispensable for basic biological research, and in numerous applied fields such as medical diagnosis, biotechnology, forensic biology, virology and biological systematics. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of complete DNA sequences, or genomes of numerous types and species of life, including the human genome and other complete DNA sequences of many animal, plant, and microbial species.
According to MRAResearch’s new survey, global Next Generation Sequencers market is projected to reach US$ 4346.4 million in 2033, increasing from US$ 3690.2 million in 2022, with the CAGR of 2.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next Generation Sequencers market research.
Key companies engaged in the Next Generation Sequencers industry include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), Roche Holding AG (Switzerland), QIAGEN N. V. (Germany), BGI (China), Macrogen Inc. (South Korea), Eurofins Scientific (Luxembourg) and Oxford Nanopore Technologies, Ltd. (UK), etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Next Generation Sequencers were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Next Generation Sequencers market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Next Generation Sequencers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Illumina, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pacific Biosciences of California, Inc. (US)
Roche Holding AG (Switzerland)
QIAGEN N. V. (Germany)
BGI (China)
Macrogen Inc. (South Korea)
Eurofins Scientific (Luxembourg)
Oxford Nanopore Technologies, Ltd. (UK)
Otogenetics Corporation (US)
Segment by Type
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-Molecule Real-time (SMRT) Sequencing
Other
Diagnostics
Drug Discovery
Biomarker Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next Generation Sequencers report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Knowledge of DNA sequences has become indispensable for basic biological research, and in numerous applied fields such as medical diagnosis, biotechnology, forensic biology, virology and biological systematics. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of complete DNA sequences, or genomes of numerous types and species of life, including the human genome and other complete DNA sequences of many animal, plant, and microbial species.
According to MRAResearch’s new survey, global Next Generation Sequencers market is projected to reach US$ 4346.4 million in 2033, increasing from US$ 3690.2 million in 2022, with the CAGR of 2.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next Generation Sequencers market research.
Key companies engaged in the Next Generation Sequencers industry include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), Roche Holding AG (Switzerland), QIAGEN N. V. (Germany), BGI (China), Macrogen Inc. (South Korea), Eurofins Scientific (Luxembourg) and Oxford Nanopore Technologies, Ltd. (UK), etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Next Generation Sequencers were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Next Generation Sequencers market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Next Generation Sequencers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pacific Biosciences of California, Inc. (US)
Roche Holding AG (Switzerland)
QIAGEN N. V. (Germany)
BGI (China)
Macrogen Inc. (South Korea)
Eurofins Scientific (Luxembourg)
Oxford Nanopore Technologies, Ltd. (UK)
Otogenetics Corporation (US)
Segment by Type
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-Molecule Real-time (SMRT) Sequencing
Other
Segment by Application
Diagnostics
Drug Discovery
Biomarker Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next Generation Sequencers report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source